SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Shilpa Medicare

BSE: 530549|NSE: SHILPAMED|ISIN: INE790G01031|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 26, 15:52
553.00
-45.05 (-7.53%)
VOLUME 33,395
LIVE
NSE
Aug 26, 15:55
551.70
-47.1 (-7.87%)
VOLUME 254,557
Announcements on Shilpa

26th-Aug-2016 14:48Source: NSE

Shilpa Medicare Limited

Shilpa Medicare Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended June 30, 2016.

26th-Aug-2016 14:46Source: BSE

Shilpa- Standalone Financial Results, Limited Review Report for June 30, 2016

Shilpa Medicare Ltd has informed BSE about :

1. Standalone Financial Results for the period ended June 30, 2016

2. Standalone Limited Review for the period ended June 30, 2016

17th-Aug-2016 14:08Source: BSE

Shilpa- Board Meeting Intimation for Results & Closure of Trading Window

Shilpa Medicare Ltd has informed BSE that a meeting of Board of Directors will be held on August 26, 2016, inter alia, to consider the un-audited financial results for the period and quarter ended Jun...

26th-Jul-2016 13:09Source: BSE

Shilpa- Updates

Shilpa Medicare Ltd has informed BSE that the Company had an audit conducted by the United States Food & Drug Administration (USFDA) at the SEZ Formulations facility situated at Jadcherla, near Hydera...

16th-Jul-2016 14:47Source: BSE

Shilpa- Shareholding for the Period Ended June 30, 2016

Shilpa Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly

9th-Jul-2016 14:56Source: BSE

Shilpa- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016

Shilpa Medicare Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing ...

4th-Jul-2016 18:10Source: BSE

Shilpa- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Tano Mauritius India FVCI II has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

27th-Jun-2016 22:29Source: BSE

Shilpa- Outcome of Board Meeting

Shilpa Medicare Ltd has informed BSE regarding Outcome of Board Meeting held on June 27, 2016.

23rd-Jun-2016 16:10Source: BSE

Shilpa- Board Meeting on June 27, 2016

Shilpa Medicare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 27, 2016, inter alia, to consider a proposal of merger of Navya Boilogicals Private Li...

8th-Jun-2016 09:17Source: NSE

Shilpa Medicare Limited

The Exchange had sought clarification from Shilpa Medicare Limited with respect to an announcement submitted to the Exchange dated May 30, 2016, regarding outcome of meeting of the Board of Directors ...

1 2 3 4 5 Next >>
Quick Links for Shilpa Medicare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.